Tempus AI Launches Next-Gen Agentic Platform to Accelerate Oncology Research

Tempus AI (TEM) has launched the next generation of its Lens platform, an agentic AI solution designed to streamline oncology drug development. The platform integrates real-world data and foundation models to provide end-to-end research capabilities for biopharma companies.

By Maham Fatima Mon, July 6, 2026 at 9:25 PM GMT+3 2 min read · Yahoo Finance · July 6, 2026, 18:25 UTC

Tempus AI Launches Next-Gen Agentic Platform to Accelerate Oncology Research

Tickers: $NVS $TEM

Topics: AI drug development oncology research

Read the full article at Yahoo Finance

More World news

Broadcom and Micron Identified as Top Alternatives to Nvidia Amid Leadership Uncertainty Motley Fool · November 12, 2026, 16:03 UTC
Thomson Reuters Executives to Present at TD Securities Technology Conference PR Newswire · November 12, 2026, 16:00 UTC
BHP to Restructure Australian Iron Ore Operations Amid Rising Costs Seeking Alpha · November 12, 2026, 15:59 UTC
Capri Investment Group and GRIT Chicago Unveil $10 Billion Bronzeville Lakefront Development Plan PR Newswire · November 12, 2026, 16:00 UTC
Whoop Launches 'Whoop Humans' Social Network to Enhance Health Data Sharing TechCrunch · November 12, 2026, 16:00 UTC
SchoolWise Partners Advises on Sale of Wyalusing Valley and Wysox Children's Centers PR Newswire · November 12, 2026, 15:57 UTC
Jensen Huang Resigns as Nvidia CEO Amid Personal Scandal and Leadership Crisis CNBC · November 12, 2026, 15:45 UTC
Keurig Dr Pepper Launches $2 Billion Equity Offering to Reduce Debt Ahead of Corporate Split Seeking Alpha · November 12, 2026, 15:51 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC
Old National Bancorp Announces Quarterly Dividend of $0.4375 per Share Seeking Alpha · November 12, 2026, 15:53 UTC